Kinexa Tablet 2.5 mg contains Rivaroxaban, a direct oral anticoagulant used to reduce the risk of blood clot–related complications in patients with cardiovascular and thrombotic conditions. Rivaroxaban belongs to the class of medicines known as Factor Xa inhibitors, which work by interrupting the blood clotting process at a specific and crucial step.

The 2.5 mg strength is a low-dose formulation, commonly prescribed in combination with other antithrombotic therapies for selected patients who require long-term prevention of thrombotic events while minimizing bleeding risk. Kinexa Tablet offers reliable anticoagulation in a convenient oral dosage form under medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Rivaroxaban selectively and directly inhibits Factor Xa, an essential enzyme in the coagulation cascade. Factor Xa is responsible for the conversion of prothrombin to thrombin, which ultimately leads to clot formation. By blocking this enzyme, Kinexa Tablet:

• Reduces thrombin generation

• Prevents fibrin clot formation

• Lowers the risk of pathological blood clots

This targeted action provides predictable anticoagulant effects and allows consistent clot prevention without routine laboratory monitoring in most cases.

Therapeutic Indications

Kinexa Tablet 2.5 mg is indicated for:

• Reduction of the risk of major cardiovascular events such as heart attack and stroke in selected high-risk patients

• Prevention of thrombotic complications in patients with coronary artery disease (CAD) or peripheral artery disease (PAD), usually in combination with antiplatelet therapy

• Long-term antithrombotic therapy as advised by a cardiologist or physician

The exact indication and treatment regimen depend on the patient’s clinical profile and risk assessment.

Dosage and Administration

• Kinexa Tablet should be taken only as prescribed by a healthcare professional.

• The usual dose is 2.5 mg once or twice daily, depending on the indication and combination therapy.

• Tablets may be taken with or without food unless otherwise advised.

• Tablets should be swallowed whole with water and not crushed or chewed.

Patients are advised to take the medicine at the same time each day to maintain consistent blood levels.

Safety Information and Precautions

• Kinexa Tablet must be used under strict medical supervision.

• Not recommended for patients with active bleeding or severe bleeding disorders.

• Use with caution in patients with kidney or liver impairment.

• Concomitant use with other anticoagulants, antiplatelet agents, or certain medicines may increase bleeding risk.

• Patients should inform their doctor about all medicines, supplements, or herbal products they are using.

Abrupt discontinuation without medical advice may increase the risk of thrombotic events.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

As with all anticoagulant medicines, the most important potential risk is bleeding. Possible side effects may include:

• Easy bruising

• Nosebleeds

• Bleeding gums

• Gastrointestinal discomfort

Any unusual, prolonged, or severe bleeding should be reported to a healthcare provider immediately.

Storage Instructions

• Store below 30°C in a dry place.

• Protect from moisture and direct sunlight.

• Keep out of reach of children.

Key Benefits of Kinexa Tablet 2.5 mg

• Low-dose anticoagulation for long-term cardiovascular protection

• Targeted Factor Xa inhibition

• Convenient oral administration

• Helps reduce the risk of serious thrombotic events

Kinexa Tablet 2.5 mg (Rivaroxaban) is an effective and well-established option for long-term antithrombotic therapy in appropriately selected patients, helping maintain cardiovascular safety when used under professional medical guidance.